PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 7.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $4,000 | -55.6% | 20,031 | +0.2% | 0.00% | – |
| Q2 2019 | $9,000 | 0.0% | 20,000 | 0.0% | 0.00% | – |
| Q1 2019 | $9,000 | +50.0% | 20,000 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | -60.0% | 20,000 | 0.0% | 0.00% | – |
| Q3 2018 | $15,000 | +66.7% | 20,000 | 0.0% | 0.00% | – |
| Q2 2018 | $9,000 | -18.2% | 20,000 | 0.0% | 0.00% | – |
| Q1 2018 | $11,000 | -15.4% | 20,000 | 0.0% | 0.00% | – |
| Q4 2017 | $13,000 | +8.3% | 20,000 | 0.0% | 0.00% | – |
| Q3 2017 | $12,000 | -29.4% | 20,000 | 0.0% | 0.00% | – |
| Q2 2017 | $17,000 | -37.0% | 20,000 | 0.0% | 0.00% | – |
| Q1 2017 | $27,000 | +200.0% | 20,000 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | -96.9% | 20,000 | -96.1% | 0.00% | – |
| Q3 2016 | $290,000 | -28.0% | 510,001 | -19.0% | 0.00% | -100.0% |
| Q2 2016 | $403,000 | – | 629,591 | -9.3% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 694,384 | -2.6% | 0.00% | -100.0% |
| Q4 2015 | $713,000 | – | 713,232 | +1251184.2% | 0.00% | – |
| Q4 2014 | $0 | – | 57 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | – | 57 | 0.0% | 0.00% | – |
| Q2 2014 | $0 | – | 57 | 0.0% | 0.00% | – |
| Q1 2014 | $0 | – | 57 | 0.0% | 0.00% | – |
| Q4 2013 | $0 | – | 57 | 0.0% | 0.00% | – |
| Q3 2013 | $0 | -100.0% | 57 | -71.6% | 0.00% | – |
| Q2 2013 | $1,000 | – | 201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|